(Reuters Health) – – Isotretinoin, a drug for severe chronic acne, has long been linked to miscarriages, birth defects and other serious problems, but a research review suggests much of data on the drug’s safety, effectiveness and side effects may be unreliabl... More »
(Reuters Health) – U.S. flight attendants may be more likely than other Americans to develop several types of cancer including tumors of the breast, uterus, cervix, thyroid and skin, new research suggests. “This study is the first to show higher prevalences of... More »
(Reuters Health) – An overactive immune response, which can occur with viral infections, could result in sudden hair graying, according to research in mice. The research revealed that a molecule involved in hair pigmentation also controls certain immune system... More »
(Reuters) – Aclaris Therapeutics Inc’s drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug Administration, the company said on Friday. It is the only topical medicine for the condition to receive... More »
By Lisa RapaportAn experimental foot-temperature monitoring system might one day be able to detect when diabetic patients are developing foot ulcers, More »
By Madeline KennedyMore than 20,000 people living in U.S. nursing homes experienced serious injuries to the face last year, mainly from falling and h More »
By Jeffrey HoskinsFoam soaps are increasingly replacing traditional liquid soaps in hospitals, nursing homes, schools, the food industry and other pu More »
By Lisa Rapaport(Reuters Health) – Skin cancers caused by indoor tanning are responsible for $343 million a year in direct medical costs for U.S. pat More »
FILE PHOTO – The Allergan logo is seen in this photo illustration in Singapore November 23, 2015. REUTERS/Thomas White/File Photo Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people ... More »
By Ronnie CohenBefore scheduling a bikini wax, or shaving down there, consider the results of a new study.Men and women who trimmed or remove More »
By Andrew M. SeamanMelanoma survivors may want to enlist partners to help search their bodies for suspicious looking moles, according to new researc More »
By Kathryn DoyleReuters – Climate change is bringing certain skin diseases and other illnesses to regions where they were rarely seen before, accordi More »
The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira. More »
Pfizer Inc (PFE.N) is buying Anacor Pharmaceuticals Inc (ANAC.O) in a $5.2 billion deal to add an eczema gel to its portfolio, a month after the U.S. drug major scrapped plans to buy Allergan Plc (AGN.N). Anacor shares rose 54 percent to $98.60 in premarket tr... More »
NEW YORK (Reuters Health) – Too few women and minorities are entering certain medical specialties in the U.S., researchers say. Diversifying the physician workforce may be key to addressing health disparities and inequities, Dr. Curtiland Deville of Johns Hopk... More »
